Akt phosphorylation is not sufficient for insulin-like growth factor-stimulated myogenin expression but must be accompanied by down-regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase phosphorylation

Endocrinology

Volumn 145, Issue 11, 2004, Pages 4991-4996

  Tiffin, Nicki ^a   Adi, Saleh ^a   Stokoe, David ^a   Wu, Nan Yan ^a   Rosenthal, Stephen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MYOGENIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; GENE; GENE EXPRESSION; MUSCLE DEVELOPMENT; MYOBLAST; MYOGENIN GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANIMALS; CELLS, CULTURED; DOWN-REGULATION; GENE EXPRESSION; INSULIN-LIKE GROWTH FACTOR I; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MYOBLASTS, SKELETAL; MYOGENIN; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; UP-REGULATION; VANADATES;

EID: 9244261026     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0101     Document Type: Article

References (38)

1. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-1) and type 1 IGF receptor (IGF1R). Cell 75:59-72
2. Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL 1998 Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA 95:15603-15607
3. Coleman ME, DeMayo F, Yin KC, Lee HM, Geske R, Montgomery C, Schwartz RJ 1995 Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem 270:12109-12116
4. Ewton DZ, Roof SL, Magri KA, McWade FJ, Florini JR 1994 IGF-II is more active than IGF-I in stimulating L6A1 myogenesis: greater mitogenic actions of IGF-I delay differentiation. J Cell Physiol 161:277-284
5. Rosenthal SM, Cheng ZQ 1995 Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts. Proc Natl Acad Sci USA 92:10307-10311
6. Engert JC, Berglund EB, Rosenthal N 1996 Proliferation precedes differentiation in IGF-I-stimulated myogenesis. J Cell Biol 135:431-440
7. Florini JR, Ewton DZ, Coolican SA 1996 Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 17:481-517
8. Hasty P, Bradley A, Morris JH, Edmondson DG, Venuti JM, Olson EN, Klein WH 1993 Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364:501-516
9. Nabeshima Y, Hanaoka K, Hayasaka M, Esumi E, Li S, Nonaka I, Nabeshima Y 1993 Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364:532-535
10. Molkentin JD, Olson EN 1996 Defining the regulatory networks for muscle development. Curr Opin Genet Dev 6:445-453
11. Florini JR, Ewton DZ, Roof SL 1991 Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression. Mol Endocrinol 5:718-724
12. LeRoith D 2000 Insulin-like growth factor I receptor signaling: overlapping or redundant pathways? Endocrinology 141:1287-1288
13. Kaliman P, Vinals F, Testar X, Palacin M, Zorzano A 1996 Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J Biol Chem 271:19146-19151
14. Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR 1997 The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J Biol Chem 272:6653-6662
15. Kaliman P, Canicio J, Shepherd PR, Beeton CA, Testar X, Palacin M, Zorzano A 1998 Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells. Mol Endocrinol 12:66-77
16. Xu Q, Wu Z 2000 The insulin-like growth factor-phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells. J Biol Chem 275:36750-36757
17. Tureckova J, Wilson EM, Cappalonga JL, Rotwein P 2001 Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J Biol Chem 276: 39264-39270
18. Winter B, Arnold HH 2000 Activated raf kinase inhibits muscle cell differentiation through a MEF2-dependent mechanism. J Cell Sci 113:4211-4220
19. Dorman CM, Johnson SE 1999 Activated Raf inhibits avian myogenesis through a MAPK-dependent mechanism. Oncogene 18:5167-5176
20. Samuel DS, Ewton DZ, Coolican SA, Petley TD, McWade FJ, Florini JR 1999 Raf-1 activation stimulates proliferation and inhibits IGF-stimulated differentiation in L6A1 myoblasts. Horm Metab Res 31:55-64
21. Weyman CM, Ramocki MB, Taparowsky EJ, Wolfman A 1997 Distinct signaling pathways regulate transformation and inhibition of skeletal muscle differentiation by oncogenic Ras. Oncogene 14:697-704
22. Bennett AM, Tonks NK 1997 Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 278:1288-1291
23. Weyman CM, Wolfman A 1998 Mitogen-activated protein kinase kinase (MEK) activity is required for inhibition of skeletal muscle differentiation by insulin-like growth factor 1 or fibroblast growth factor 2. Endocrinology 139: 1794-1800
24. Sarbassov DD, Peterson CA 1998 Insulin receptor substrate-1 and phosphatidylinositol 3-kinase regulate extracellular signal-regulated kinase-dependent and -independent signaling pathways during myogenic differentiation. Mol Endocrinol 12:1870-1878
25. Gredinger E, Gerber AN, Tamir Y, Tapscott SJ, Bengal E 1998 Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells. J Biol Chem 273:10436-10444
26. Adi S, Bin-Abbas B, Wu NY, Rosenthal SM 2002 Early stimulation and late inhibition of extracellular signal-regulated kinase 1/2 phosphorylation by IGF-I: a potential mechanism mediating the switch in IGF-I action on skeletal muscle cell differentiation. Endocrinology 143:511-516
27. Nadal-Ginard B 1978 Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis. Cell 15:855-864
28. Ballard FJ, Francis GL, Rose M, Bagley CJ, May B, Wallace JC 1987 Natural and synthetic forms of insulin-like growth factor-1 (IGF-1) and the potent derivative, destripeptide IGF-1: biological activities and receptor binding. Biochem Biophys Res Commun 149:398-404
29. Morgenstern JP, Land H 1990 Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 18:3587-3596
30. Bosch E, Cherwinski H, Peterson D, McMahon M 1997 Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1. Oncogene 15:1021-1033
31. Aziz N, Cherwinski H, McMahon M 1999 Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src. Mol Cell Biol 19:1011-1015
32. Adi S, Cheng ZQ, Zhang PL, Wu NY, Mellon SH, Rosenthal SM 2000 Opposing early inhibitory and late stimulatory effects of insulin-like growth factor-I on myogenin gene transcription. J Cell Biochem 78:617-626
33. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR 1995 PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489-27494
34. Vinals F, Pouyssegur J 1999 Confluence of vascular endothelial cells induces cell cycle exit by inhibiting p42/p44 mitogen-activated protein kinase activity. Mol Cell Biol 19:2763-2772
35. Zhang L, Bewick M, Lafrenie RM 2002 Role of Raf-1 and FAK in cell density-dependent regulation of integrin-dependent activation of MAP kinase. Carcinogenesis 23:1251-1258
36. Jacobsen K, Groth A, Willumsen BM 2002 Ras-inducible immortalized fibroblasts: focus formation without cell cycle deregulation. Oncogene 21:3058-3067
37. Suzuki E, Nagata D, Yoshizumi M, Kakoki M, Goto A, Omata M, Hirata Y 2000 Reentry into the cell cycle of contact-inhibited vascular endothelial cells by a phosphatase inhibitor. Possible involvement of extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J Biol Chem 275:3637-3644
38. Sarbassov DD, Jones LG, Peterson CA 1997 Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signaling pathways in myoblasts. Mol Endocrinol 11:2038-2047